Third Rock invests $55M in ‘kidney renaissance’ startup
Third Rock Ventures has incubated, funded and launched another startup, Goldfinch Bio, committing $55M to its mission to modernize the treatment of kidney disease.
Third Rock Ventures has incubated, funded and launched another startup, Goldfinch Bio, committing $55M to its mission to modernize the treatment of kidney disease.
Today is World Kidney Day, and Bloomington, Indiana-based medical device company Cook Medical is bringing awareness to chronic kidney disease (CKD) with a new campaign.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Investment driven from Baxter Ventures and Boston Scientific Corporation has brought TVA Medical up by $15 million.
The color of your urine could be telling you something about your health condition. Yes, your standard yellow is where you want to be, but the different shades of the rainbow make an appearance on occasion. It’s not always scary when you’re pee is red, for example. Eating beets can result in beeturia—the passing of red or […]
A first-of-its-kind laboratory test to gauge severe acute kidney injury has been approved for marketing by the Food and Drug Administration. Developed by San Diego’s Astute Medical, the NephroCheck test is meant to be used in critically ill, hospitalized patients. It can gauge whether a patient pool that generally consists of diabetics, the elderly and those […]
Scientists in Wales have potentially uncovered a new way to quickly identify bacterial infections using clues given off by a patient’s so-called immune fingerprint. Working with chronic kidney disease patients who acquired infections during dialysis, researchers at Cardiff University’s School of Medicine in the UK showed proof-of-concept that a person’s “immune fingerprint” reflected which organism […]
Biocrossroads, which provides money and support to Indiana’s life sciences industry, announced the seven finalists who stand to gain startup funding in its annual New Venture Competition. Six have biotech or healthcare in their sights. On Oct. 21, five of these companies will compete for $25,000 and access to the Indiana Seed II Fund‘s staff […]
Medtronic (MDT) has signed a deal with Apollo Hospitals Enterprise to develop a new hemodialysis system to help patients with end-stage renal disease (ESRD). The medical devices company will cover the technology, Apollo the “clinical insight.” This collaboration marks the first instance Medtronic will use a full India-based R&D team. Medtronic said it will develop […]
A Duke University spinoff has reached a milestone in tissue engineering as it transplanted the first bioengineered blood vessel into the arm of a patient with end-stage kidney disease. In its first U.S. clinical trial, Humacyte is testing the safety and effectiveness of the blood vessel, which is intended to be an off-the-shelf product that’s […]
Akebia Therapeutics might be a bit behind in the race to develop a safer, oral drug for anemia, but it’s just gotten a big vote of confidence from investors in the form of a $41 million Series C. Novartis Venture Fund, Kearny Venture Partners, Venture Investors LLC, Athenian Venture Partners, Triathlon Medical Ventures, AgeChem Venture […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
For the more than 870,000 patients in the U.S. being treated for end-stage renal disease, hemodialysis treatments become part of a daily or multiple-times-a-week routine. In order to perform dialysis, clinicians must create long-term, high-flow access to a patient’s blood vessels. But current access options, like arteriovenous fistulas, arteriovenous grafts and central venous catheters, can […]
The start of Q2 means the nearing of a big milestone for Pittsburgh drug startup Complexa Inc. — if it can raise the necessary capital. Complexa is looking for a $7 million Series B so that it can file its Investigational New Drug Application early this summer and begin its first in-human trials in August. […]
Kidneys from deceased donors are carefully rationed under rules established by the nonprofit United Network for Organ Sharing, or UNOS. The system is set up so that kidneys go to people who have spent the longest time on waiting lists and who are a goo...